Monika Scheer

1.4k total citations
38 papers, 622 citations indexed

About

Monika Scheer is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Monika Scheer has authored 38 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 14 papers in Pathology and Forensic Medicine and 10 papers in Rheumatology. Recurrent topics in Monika Scheer's work include Sarcoma Diagnosis and Treatment (32 papers), Cardiac tumors and thrombi (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Monika Scheer is often cited by papers focused on Sarcoma Diagnosis and Treatment (32 papers), Cardiac tumors and thrombi (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). Monika Scheer collaborates with scholars based in Germany, Poland and Austria. Monika Scheer's co-authors include Ewa Kościelniak, Anton G. Henssen, Stefan Bielack, Celine Chen, Heathcliff Dorado García, Christian Vokuhl, Monika Sparber‐Sauer, Thekla von Kalle, Thomas Klingebiel and Felix Niggli and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Monika Scheer

36 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monika Scheer Germany	16	429	195	156	150	103	38	622
Florian Puls United Kingdom	19	588 1.4×	257 1.3×	375 2.4×	131 0.9×	174 1.7×	44	968
Yasuo Yazawa Japan	13	368 0.9×	274 1.4×	143 0.9×	96 0.6×	77 0.7×	51	635
Huichun Tai Taiwan	12	261 0.6×	91 0.5×	219 1.4×	100 0.7×	177 1.7×	18	558
Jordi Rubió‐Casadevall Spain	13	430 1.0×	363 1.9×	32 0.2×	84 0.6×	139 1.3×	44	771
Masachika Ikegami Japan	12	183 0.4×	180 0.9×	78 0.5×	96 0.6×	165 1.6×	63	516
Yuji Taniguchi Japan	17	334 0.8×	221 1.1×	40 0.3×	53 0.4×	125 1.2×	80	745
Lobna Ayadi Tunisia	14	134 0.3×	191 1.0×	68 0.4×	139 0.9×	147 1.4×	87	613
Federica Castri Italy	16	172 0.4×	147 0.8×	46 0.3×	45 0.3×	73 0.7×	38	555
Michèle Brun France	5	803 1.9×	105 0.5×	132 0.8×	87 0.6×	68 0.7×	8	938
D. Söhngen Germany	16	144 0.3×	113 0.6×	87 0.6×	88 0.6×	58 0.6×	55	900

Countries citing papers authored by Monika Scheer

Since Specialization

Citations

This map shows the geographic impact of Monika Scheer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Scheer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Scheer more than expected).

Fields of papers citing papers by Monika Scheer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Scheer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Scheer. The network helps show where Monika Scheer may publish in the future.

Co-authorship network of co-authors of Monika Scheer

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Scheer. A scholar is included among the top collaborators of Monika Scheer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Scheer. Monika Scheer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henssen, Anton G., et al.. (2025). Rhabdomyosarcoma of head and neck varies in aggressiveness depending on the specific site of origin. Oral Oncology. 164. 107263–107263.

Henssen, Anton G., et al.. (2024). The Other Site of Rhabdomyosarcoma. Cancer Medicine. 13(20). e70348–e70348.

Tramsen, Lars, Konrad Bochennek, Monika Sparber‐Sauer, et al.. (2023). Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers. 15(7). 2050–2050. 13 indexed citations

Kościelniak, Ewa, Beate Timmermann, Marc Münter, et al.. (2023). Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry. Journal of Clinical Oncology. 41(31). 4916–4926. 5 indexed citations

Thorwarth, Anne, Kerstin Haase, Claudia Röefzaad, et al.. (2022). Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring anNTRKOncogenic Fusion. JCO Precision Oncology. 6(6). e2100283–e2100283. 3 indexed citations

Scheer, Monika, Erika Hallmen, Christian Vokuhl, et al.. (2022). Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma. Journal of Cancer Research and Clinical Oncology. 149(5). 1717–1731. 3 indexed citations

Orbach, Daniel, Monika Sparber‐Sauer, Theodore W. Laetsch, et al.. (2020). Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies. European Journal of Cancer. 137. 183–192. 33 indexed citations

Meister, Michael T., Monika Scheer, Erika Hallmen, et al.. (2020). Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Journal of Surgical Oncology. 122(7). 1337–1347. 7 indexed citations

Doyen, J., Danny Jazmati, Dirk Geismar, et al.. (2019). Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy. International Journal of Radiation Oncology*Biology*Physics. 105(5). 1043–1054. 18 indexed citations

10.

Bielack, Stefan, M.C. Cox, Michaela Nathrath, et al.. (2019). Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. Annals of Oncology. 30(Suppl_8). viii31–viii35. 28 indexed citations

11.

Kather, Jakob Nikolas, Cleo‐Aron Weis, Thiha Aung, et al.. (2019). CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma. Scientific Reports. 9(1). 9211–9211. 37 indexed citations

12.

Chen, Celine, Heathcliff Dorado García, Monika Scheer, & Anton G. Henssen. (2019). Current and Future Treatment Strategies for Rhabdomyosarcoma. Frontiers in Oncology. 9. 1458–1458. 100 indexed citations

13.

Sparber‐Sauer, Monika, Christian Vokuhl, Guido Seitz, et al.. (2019). The impact of local control in the treatment of children with advanced infantile and adult-type fibrosarcoma: Experience of the cooperative weichteilsarkom studiengruppe (CWS). Journal of Pediatric Surgery. 55(9). 1740–1747. 15 indexed citations

14.

Sparber‐Sauer, Monika, Ewa Kościelniak, Christian Vokuhl, et al.. (2019). Epithelioid sarcoma in children, adolescents, and young adults: Localized, primary metastatic and relapsed disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. Pediatric Blood & Cancer. 66(9). e27879–e27879. 10 indexed citations

15.

Vokuhl, Christian, Tobias M. Dantonello, Monika Scheer, et al.. (2018). Inflammatory myofibroblastic tumors—A retrospective analysis of the Cooperative Weichteilsarkom Studiengruppe. Pediatric Blood & Cancer. 65(6). e27012–e27012. 32 indexed citations

16.

Sparber‐Sauer, Monika, Guido Seitz, Thekla von Kalle, et al.. (2018). Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric Blood & Cancer. 65(5). e26943–e26943. 17 indexed citations

17.

Dantonello, Tobias M., Christian Vokuhl, Monika Scheer, et al.. (2018). Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(3). 441–449. 4 indexed citations

18.

Scheer, Monika, et al.. (2016). Creatine and creatine pyruvate reduce hypoxia-induced effects on phrenic nerve activity in the juvenile mouse respiratory system. Experimental and Molecular Pathology. 101(1). 157–162. 6 indexed citations

19.

Watzka, Matthias, Christof Geisen, Monika Scheer, et al.. (2014). Bleeding and non-bleeding phenotypes in patients with GGCX gene mutations. Thrombosis Research. 134(4). 856–865. 30 indexed citations

20.

Heinrich, Marc, Monika Scheer, M Heckmann, Michael A. Kuefner, & Michael Uder. (2009). Iodixanol Induces Apoptotic and Antiproliferative Effects but no Necrotic Cell Death in Renal Proximal Tubular Cells In Vitro. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 181(4). 349–354. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact